Evidence map›Paper›PMID 39393288›Full record

ArticleRedox biology2024

A quantitative proteomic approach to evaluate the efficacy of carnosine in a murine model of chronic obstructive pulmonary disease (COPD).

Alfonsina D'Amato, Alessandra Altomare, Ettore Gilardoni, Giovanna Baron, Marina Carini, Elsa Melloni, Gloria Padoani, Silvia Vailati, Giovanni Caponetti, Giancarlo Aldini

Abstract read
In one paragraph

Article in Redox biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alfonsina D'AmatoDepartment of Pharmaceutical Sciences (DISFARM), Università Degli Studi di Milano, Via Mangiagalli 25, 20133, Milan, Italy.
Alessandra AltomareDepartment of Pharmaceutical Sciences (DISFARM), Università Degli Studi di Milano, Via Mangiagalli 25, 20133, Milan, Italy.
Ettore GilardoniDepartment of Pharmaceutical Sciences (DISFARM), Università Degli Studi di Milano, Via Mangiagalli 25, 20133, Milan, Italy.
Giovanna BaronDepartment of Pharmaceutical Sciences (DISFARM), Università Degli Studi di Milano, Via Mangiagalli 25, 20133, Milan, Italy.
Marina CariniDepartment of Pharmaceutical Sciences (DISFARM), Università Degli Studi di Milano, Via Mangiagalli 25, 20133, Milan, Italy.
Elsa MelloniZambon S.p.A., Via Lillo del Duca 11, 20091, Bresso, Italy.
Gloria PadoaniZambon S.p.A., Via Lillo del Duca 11, 20091, Bresso, Italy.
Silvia VailatiZambon S.p.A., Via Lillo del Duca 11, 20091, Bresso, Italy.
Giovanni CaponettiZambon S.p.A., Via Lillo del Duca 11, 20091, Bresso, Italy.
Giancarlo AldiniDepartment of Pharmaceutical Sciences (DISFARM), Università Degli Studi di Milano, Via Mangiagalli 25, 20133, Milan, Italy. Electronic address: giancarlo.aldini@unimi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the work was to study a dose-dependent effect of inhaled carnosine (10, 50 or 100 mg/kg/day) in mice exposed to cigarette smoke as a model of chronic obstructive pulmonary disease (COPD). A dose-dependent loading of the dipeptide in lung tissue and bronchoalveolar lavage (BAL) was firstly demonstrated by LC-ESI-MS analysis. Cigarette smoke exposure induced a significant lung inflammation and oxidative stress in mice which was dose-dependently reduced by carnosine. Inflammation was firstly evaluated by measuring the cytokines content in the BAL. All the measured cytokines were found significantly higher in the smoke group in respect to control, although the data are affected by a significant variability. Carnosine was found effective only at the highest dose tested and significantly only for keratinocyte-derived cytokine (KC). Due to the high variability of cytokines, a quantitative proteomic approach to better understand the functional effect of carnosine and its molecular mechanisms was used. Proteomic data clearly indicate that smoke exposure had a great impact on lung tissue with 692 proteins differentially expressed above a threshold of 1.5-fold. Protein network analysis identified the activation of some pathways characteristic of COPD, including inflammatory response, fibrosis, induction of immune system by infiltration and migration of leukocyte pathways, altered pathway of calcium metabolism and oxidative stress. Carnosine at the tested dose of 100 mg/kg was found effective in reverting all the pathways evoked by smoke. Only a partial reverse of the dysregulated proteins was evident at low- and mid-tested doses, although, for some specific proteins, indicating an overall dose-dependent effect. Regarding the molecular mechanisms involved, we found that carnosine upregulated some key enzymes related to Nrf2 activation and in particular glutathione peroxidase, reductase, transferase, SOD, thioredoxins, and carbonyl reductase. Such mechanism would explain the antioxidant and anti-inflammatory effects of the dipeptide.

Indexed as

CarnosineCytokinesDisease Models, AnimalOxidative StressProteomicsPulmonary Disease, Chronic ObstructiveAnimalsBronchoalveolar Lavage FluidLungMaleMiceProteomeCarnosineCytokinesProteomeCarnosineChronic obstructive pulmonary disease (COPD)Cigarette smokeInflammationNrf2Oxidative stressQuantitative proteomic

Identifiers

PMID39393288
PMCPMC11663752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.